Live AI theses that have not passed the Gate. The Lab is the front of the Studio: where ideas are tested, and where most of them stay.
None of these is a Company until a buyer and a data set sit down together.
The operator is the mechanical lead who has piped a CDU. A company once a pilot is paid.
The operator is the independent power producer. Margin on the uplift.
Distribution that already exists, borrowed with permission. The Studio holds the equity and the Chair.
The operator is the chief mate and the independent broker. Compliance plus a cut of fuel and time.
Elevate a partner who already holds the clients and the liability. Built on the partner’s own matter history.
On the stack. A Chair once a buyer and a closed data set sit down together.
A lane earns a Chair at the Gate. Naming the lane publicly costs nothing and keeps the Studio honest about how few of them become Companies.
We build Companies at the intersection of artificial intelligence, biology, medicine and the physical delivery of healthcare, from scientific discovery all the way to the patient's front door.
Drug discovery, protein and antibody design, target and biomarker discovery, biological foundation models, and self-driving laboratories where AI proposes, robotics runs and AI interprets the next experiment.
Imaging, pathology, cardiology, ophthalmology, genomics and wearables, moving from single findings toward a longitudinal model of each patient.
Hospitals, clinicians, nursing, pharmacy, distribution, revenue cycle, prior authorization and home care. Workflow orchestration that executes everything that should happen after the visit.
Clinical trials, precision medicine, gene and RNA therapies, and post-market monitoring, from patient matching and site selection to earlier go and no-go decisions.
Most healthcare AI Companies attack one workflow. The harder-to-copy Companies connect two systems.
Healthcare AI demands a clinical and regulatory operating layer from day one: validation, lifecycle management, post-deployment monitoring and human oversight of consequential decisions.
Reimbursement, regulators and hospital systems differ in every market. The Kingdoms bring the hospital, regulator, distributor and operator relationships a Company needs to enter Riyadh, Tokyo or Bangalore.
Physicians, Scientists and Operators. We are looking for the people who see what healthcare could become before the market does.
Intelligence becomes physical. Every horizon moves the value further from the model and closer to the plant.
Own the picks and shovels: data and a channel.
One human manages ten agents. Headcount stops being the product.
Robots reach the labour economy: halls, warehouses and hospitals.
Helping the doctor becomes designing the molecule.
Own the machines as well as the model.
Energy is the constraint. Space is economic when the crew is robotic.
The market thesis behind these horizons is written at Redrock Ventures. Read the Thesis
The Lab creates the AI business. The Studio gives it a body.
An operator who has run the job takes the Chair of a Company that already stands.
A business with a roster, a plant, a license or a book keeps its customers and gains the same Chair and the same governance.
Crowning either one is a kingmaker move. The AI business is the constant. The body is the variable.